Sonoma Pharmaceuticals (SNOA) Inventory (2011 - 2025)

Sonoma Pharmaceuticals' Inventory history runs 15 years deep, the most recent figure standing at $4.0 million for Q4 2025.

• In Q4 2025, Inventory rose 27.87% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 27.87% YoY), while the FY2025 annual figure was $3.2 million, up 6.57% from the prior year.
• Inventory was $4.0 million for Q4 2025 at Sonoma Pharmaceuticals, up from $3.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $4.0 million in Q4 2025 to a low of $2.5 million in Q3 2021.
• Historically, Inventory has averaged $3.0 million across 5 years, with a median of $2.9 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Inventory tumbled 37.51% in 2021, then jumped 43.04% in 2025.
• A 5-year view of Inventory shows it stood at $2.9 million in 2021, then dropped by 1.04% to $2.8 million in 2022, then gained by 3.72% to $3.0 million in 2023, then rose by 6.36% to $3.1 million in 2024, then rose by 27.87% to $4.0 million in 2025.
• The last three Inventory figures came in at $4.0 million (Q4 2025), $3.9 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.